Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2025
Posted On Friday, May 02, 2025
Coherus to Participate in Upcoming Investor Conferences
Posted On Thursday, May 01, 2025
Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules
Posted On Thursday, May 01, 2025
MacroGenics to Participate in Upcoming Investor Conference
Posted On Thursday, May 01, 2025
Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
Posted On Thursday, May 01, 2025
Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
Posted On Thursday, May 01, 2025
Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights
Posted On Thursday, May 01, 2025
Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy
Posted On Thursday, May 01, 2025
Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
Posted On Thursday, May 01, 2025
Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements
Posted On Thursday, May 01, 2025
Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference
Posted On Thursday, May 01, 2025
Kura Oncology Reports First Quarter 2025 Financial Results
Posted On Thursday, May 01, 2025
Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations
Posted On Thursday, May 01, 2025
NextCure Provides Business Update and Reports First Quarter 2025 Financial Results
Posted On Thursday, May 01, 2025
Sutro Biopharma to Participate in Upcoming Investor Conferences
Posted On Thursday, May 01, 2025
89bio Reports First Quarter 2025 Financial Results and Corporate Updates
Posted On Thursday, May 01, 2025
scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences
Posted On Thursday, May 01, 2025
Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update
Posted On Thursday, May 01, 2025
Aura Biosciences to Participate in Upcoming Investor Conferences
Posted On Thursday, May 01, 2025
Ascendis Pharma Reports First Quarter 2025 Financial Results
Posted On Thursday, May 01, 2025
Eascra Biotech Expands Operations with a New Worcester Lab
Posted On Thursday, May 01, 2025
BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting
Posted On Thursday, May 01, 2025
Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates
Posted On Thursday, May 01, 2025
Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
Posted On Thursday, May 01, 2025
Enara Bio Strengthens Senior Leadership with Key Executive and Board Appointments Alongside Acceleration of Multiple T-Cell Engager Programs
Posted On Thursday, May 01, 2025

Print